Literature DB >> 2505753

Insulin controls key steps of carbohydrate metabolism in cultured HT29 colon cancer cells.

T Babia1, C Denis-Pouxviel, J C Murat, A M Gomez-Foix, V Trocheris, J J Guinovart, F Bosch.   

Abstract

Effects of insulin on key steps of carbohydrate metabolism were investigated in cultured HT29 colon cancer cells by two different approaches, i.e. incubation of the cells either in the absence or in the presence of glucose in the medium. In glucose-deprived cells, insulin decreased glycogen breakdown, but did not affect polysaccharide levels when glucose was present. Glycogen synthase became activated after insulin treatment in both conditions, even though the activation was more evident when glucose was omitted. No effect on glycogen phosphorylase activity was evident under our experimental conditions. In cells incubated with glucose, the hormone stimulated in a dose-dependent manner the rates of glucose uptake and lactate release. Concomitantly with the increase in glycolytic rate, insulin caused a strong increase in fructose 2,6-bisphosphate. This effect was not observed in the absence of glucose. It is concluded that the carbohydrate metabolism of cultured HT29 cells responds to insulin, making this biological model suitable for investigations in vitro on the mechanism of insulin action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505753      PMCID: PMC1138797          DOI: 10.1042/bj2610175

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  BEHAVIOR AND REGULATION OF ENZYME SYSTEMS IN NORMAL LIVER AND IN HEPATOMAS OF DIFFERENT GROWTH RATES.

Authors:  G WEBER
Journal:  Adv Enzyme Regul       Date:  1963

2.  Control of glycogen synthase and phosphorylase by insulin in rat adipocytes which is unrelated to the concentration of cyclic AMP.

Authors:  J C Lawrence; J Larner
Journal:  Biochim Biophys Acta       Date:  1979-02-01

3.  Activity of glycogen metabolizing enzymes in glucose deprived HT 29 adenocarcinoma cell-line.

Authors:  H Paris; B Terrain; V Viallard; M Rousset; A Zweibaum; J C Murat
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575

4.  A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate.

Authors:  E Van Schaftingen; B Lederer; R Bartrons; H G Hers
Journal:  Eur J Biochem       Date:  1982-12

5.  Insulin activation of basal hepatic glycogen synthase.

Authors:  C J Ciudad; F Bosch; J J Guinovart
Journal:  FEBS Lett       Date:  1981-06-29       Impact factor: 4.124

Review 6.  Methods for growth of cultured cells in serum-free medium.

Authors:  D Barnes; G Sato
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

7.  Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells.

Authors:  M Rousset; H Paris; G Chevalier; B Terrain; J C Murat; A Zweibaum
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

8.  Growth-promoting effect, biological activity, and binding of insulin in human intestinal cancer cells in culture.

Authors:  J P Cezard; M E Forgue-Lafitte; M C Chamblier; G E Rosselin
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

9.  Insulin receptor regulation in cultured human tumor cells.

Authors:  K G Mountjoy; I M Holdaway; G J Finlay
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

10.  Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture.

Authors:  M Rousset; M Laburthe; G Chevalier; C Boissard; G Rosselin; A Zweibaum
Journal:  FEBS Lett       Date:  1981-04-06       Impact factor: 4.124

View more
  1 in total

1.  Phosphofructokinase 2 and glycolysis in HT29 human colon adenocarcinoma cell line. Regulation by insulin and phorbol esters.

Authors:  C Denis-Pouxviel; T Gauthier; D Daviaud; J C Murat
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.